Hepatocyte Marker Antibody / Hepatocyte Marker Antibodies

Hepatocyte Marker Antibody Overview

Hepatocyte Marker Antibody reagents target proteins expressed in liver parenchymal cells, the hepatocytes. Hepatocytes represent the majority of the liver’s cellular mass and are central to metabolism, detoxification, bile production, and protein synthesis. Because of their unique functions, hepatocytes express a panel of markers that help distinguish them from other liver cell types such as Kupffer cells, stellate cells, and endothelial cells.

Common hepatocyte markers include albumin, hepatocyte nuclear factor 4 alpha (HNF4α), cytokeratins 8/18, and carbamoyl phosphate synthetase 1 (CPS1). These proteins are widely used to confirm hepatocyte identity in tissue biopsies, cell culture models, and regenerative medicine. The Hepatocyte Marker Antibody is essential for identifying hepatocytes in both research and diagnostic settings, while Hepatocyte Marker Antibodies more broadly support investigations into liver physiology, toxicology, and disease.

Why Choose Hepatocyte Marker Antibodies from NSJ Bioreagents?

NSJ Bioreagents provides Hepatocyte Marker Antibodies validated for immunohistochemistry, western blotting, immunofluorescence, ELISA, and flow cytometry. Each Hepatocyte Marker Antibody undergoes strict validation to ensure high specificity and minimal cross-reactivity with non-hepatocyte proteins.

By choosing Hepatocyte Marker Antibodies from NSJ Bioreagents, scientists gain reagents optimized for reproducibility. Our antibodies deliver strong, clear staining in liver tissue, reliable protein detection in lysates, and consistent performance across multiple assays. Detailed datasheets, recommended controls, and optimized protocols support accurate and reproducible outcomes.

Applications of Hepatocyte Marker Antibodies

The Hepatocyte Marker Antibody is widely used in both basic and clinical research.

1) Liver Biology and Development

• Hepatocyte Marker Antibodies highlight liver-specific proteins such as albumin and HNF4α.

• The Hepatocyte Marker Antibody helps study hepatocyte differentiation and maturation.

• Hepatocyte Marker Antibodies support research into liver development and regeneration.

2) Toxicology and Drug Testing

• Hepatocyte Marker Antibodies are applied in toxicology studies to confirm hepatocyte identity in cultures.

• The Hepatocyte Marker Antibody ensures accurate detection of hepatotoxic effects.

• Hepatocyte Marker Antibodies support drug safety studies by monitoring liver cell health.

3) Pathology and Diagnostics

• Hepatocyte Marker Antibodies help distinguish primary liver tumors such as hepatocellular carcinoma from metastatic lesions.

• The Hepatocyte Marker Antibody validates hepatocyte origin in biopsy samples.

• Hepatocyte Marker Antibodies provide diagnostic clarity in liver disease research.

4) Oncology and Tumor Biology

• Hepatocyte Marker Antibodies identify hepatocyte lineage in cancer studies.

• The Hepatocyte Marker Antibody supports research into tumor heterogeneity and progression.

• Hepatocyte Marker Antibodies help in biomarker discovery for prognosis and therapy development.

5) Stem Cell and Regenerative Medicine

• Hepatocyte Marker Antibodies validate differentiation of stem cells into hepatocyte-like cells.

• The Hepatocyte Marker Antibody ensures correct lineage specification in tissue engineering.

• Hepatocyte Marker Antibodies support the development of regenerative therapies for liver disease.

6) Infectious Disease

• Hepatocyte Marker Antibodies are applied in studies of hepatitis virus infection.

• The Hepatocyte Marker Antibody supports analysis of host–pathogen interactions in liver tissue.

7) Translational Medicine and Clinical Research

• Hepatocyte Marker Antibodies are used to validate biomarkers in hepatology clinical trials.

• The Hepatocyte Marker Antibody provides tools for personalized medicine approaches in liver disease.

Why Are Hepatocyte Marker Antibodies Important?

The liver plays a central role in metabolism, detoxification, and systemic health, making hepatocyte markers invaluable for biomedical research. The Hepatocyte Marker Antibody enables precise identification of hepatocytes, while Hepatocyte Marker Antibodies more broadly support research into liver biology, toxicology, oncology, and regenerative medicine.

In basic science, these antibodies clarify hepatocyte function and differentiation. In toxicology, the Hepatocyte Marker Antibody validates drug safety studies. In oncology, Hepatocyte Marker Antibodies help distinguish primary liver cancers from metastatic lesions.

Clinically, hepatocyte markers are used in diagnostic pathology and in monitoring regenerative therapies. By providing reliable detection, the Hepatocyte Marker Antibody ensures that liver research translates effectively into clinical applications.

Conclusion

Hepatocyte-specific markers are vital for distinguishing parenchymal liver cells in research and diagnostics. The Hepatocyte Marker Antibody equips scientists and clinicians with a precise tool for identifying hepatocytes, while Hepatocyte Marker Antibodies more broadly support studies in hepatology, toxicology, oncology, and regenerative biology. By bridging molecular research with clinical application, these antibodies remain indispensable for advancing liver science and improving patient outcomes.